MicroApproach Medical

MicroApproach Medical is a Shenzhen-based company dedicated to the development and commercialization of endovascular medical devices. Established in 2015, the company has received a Venture Round investment in May 17, 2021, with Neovision Capital as the investor. The company's focus on intravascular intervention medical devices has earned it recognition as the "Engineering Technology Center of Endovascular Medical Devices" by the Shenzhen Science and Technology Innovation Committee. MicroApproach Medical has built strong partnerships with reputable institutions such as Beijing Tiantan Hospital, the People's Liberation Army 301 Hospital, Wuhan Tongji Hospital, China Medical University, and Shenzhen People's Hospital, showcasing its commitment to collaboration and research. MicroApproach Medical operates under the principles of "Quality First & Respect for Life," with a corporate culture centered around "Innovation, Enterprise, Pragmatism, Cooperation, and Win-Win." The organization is dedicated to providing high-quality intravascular intervention products to medical professionals and patients, contributing to advancements in endovascular intervention medical devices in China. Furthermore, the company has implemented a robust management system for medical device production and constructed a state-of-the-art industrial production line for hydrophilic coating guide wires. With a registered capital of 30 million yuan and a top-tier R&D team, MicroApproach Medical is poised to make significant strides in the field of endovascular medical devices.